Atomfair

Awaiting product image

Atomfair Imidafenacin C20H21N3O

Description Imidafenacin (CAS No. 170108-05-1) is a highly selective antimuscarinic agent with the molecular formula C20H21N3O and IUPAC name 4-(2-methylimidazol-1-yl)-2,2-diphenylbutanamide . This pharmaceutical compound is widely recognized for its potent and specific antagonistic activity on the M3muscarinic receptor subtype, making it a valuable tool in urological research and therapeutic development. Imidafenacin is supplied as a high-purity reference standard (>98%) with comprehensive analytical data including HPLC, NMR, and MS for quality assurance. Its low hygroscopicity and stable crystalline form ensure long-term storage suitability. Available in milligram to gram quantities, this product is ideal for pharmacological studies, receptor binding assays, and drug…

Category:
Brands:

Description

Description

Imidafenacin (CAS No. 170108-05-1) is a highly selective antimuscarinic agent with the molecular formula C20H21N3O and IUPAC name 4-(2-methylimidazol-1-yl)-2,2-diphenylbutanamide. This pharmaceutical compound is widely recognized for its potent and specific antagonistic activity on the M3 muscarinic receptor subtype, making it a valuable tool in urological research and therapeutic development. Imidafenacin is supplied as a high-purity reference standard (>98%) with comprehensive analytical data including HPLC, NMR, and MS for quality assurance. Its low hygroscopicity and stable crystalline form ensure long-term storage suitability. Available in milligram to gram quantities, this product is ideal for pharmacological studies, receptor binding assays, and drug metabolism investigations. Synonyms include Uritos, Staybla, and KRP-197.

  • CAS No: 170108-05-1
  • Molecular Formula: C20H21N3O
  • Molecular Weight: 319.4
  • Exact Mass: 319.168462302
  • Monoisotopic Mass: 319.168462302
  • IUPAC Name: 4-(2-methylimidazol-1-yl)-2,2-diphenylbutanamide
  • SMILES: CC1=NC=CN1CCC(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N
  • Synonyms: Imidafenacin, 170105-16-5, Uritos, Staybla, KRP-197

Application

Imidafenacin is primarily used as a research compound for studying overactive bladder (OAB) syndrome due to its selective M3 muscarinic receptor blockade. Researchers employ this agent to investigate detrusor muscle contraction mechanisms and urinary frequency pathophysiology. The compound serves as a reference standard in pharmacokinetic studies of anticholinergic drugs. Preclinical studies utilize imidafenacin to explore tissue selectivity profiles in bladder versus salivary glands.

If you are interested or have any questions, please contact us at support@atomfair.com